|

[68Ga]Ga-DPI-4452 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • ITM Oncologics GmbH1

Indications

  • Squamous Non-Small Cell Lung Cancer (NSCLC)1
  • Indeterminate Renal Mass (IDRM)1
  • Head and Neck Cancer (H&N)1
  • Clear Cell Renal Cell Cancer (ccRCC)1
  • Urothelial Carcinoma (UC)1

Other1 trial

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.